a2z Radiology AI vs Storylane

Side-by-side comparison of AI visibility scores, market position, and capabilities

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Storylane

EmergingMarketing

Marketing Automation

No-code interactive product demo platform for B2B SaaS sales; $1.9M revenue YC-backed serving Nasdaq and Microsoft at 3.5x YoY growth competing with Navattic and Walnut for sales enablement demos.

AI VisibilityBeta
Overall Score
C42
Category Rank
#34 of 34
AI Consensus
56%
Trend
stable
Per Platform
ChatGPT
47
Perplexity
43
Gemini
50

About

Storylane is a San Francisco-based interactive product demo software company enabling B2B SaaS sales and marketing teams to create no-code interactive product demos that sales reps can share with prospects, embed on websites, and use in outbound email sequences — with demos built in under 10 minutes without engineering involvement. Founded in 2021 and backed by Y Combinator with $130,000 initial funding, Storylane generated $1.9 million in revenue in 2024 (3.5x year-over-year growth), was recognized as G2's 6th fastest-growing software product in 2024, and acquired PreSkale in 2024 to expand into presales automation.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.